Intravitreal infliximab

DRUG2 trials

Sponsors

Cairo University

Conditions

Behçet's DiseaseProliferative VitreoretinopathyRetinal DetachmentRhegmatogenous Retinal DetachmentUveitis

Phase 1

Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study

CompletedNCT02620618

Cairo UniversityBehçet's Disease, Uveitis

Start: 2013-01-31End: 2014-12-31Updated: 2015-12-03

Phase 2

Intravitreal Infliximab for Proliferative Vitreoretinopathy

CompletedNCT04891991

Cairo UniversityProliferative Vitreoretinopathy, Retinal Detachment, Rhegmatogenous Retinal Detachment

Start: 2021-11-26End: 2023-11-10Updated: 2024-01-19